Dec 4th, 2021 - NEW ORLEANS —In this Healio Video Perspective from the Eyecelerator meeting, Jag Dosanjh, senior vice president of U.S. eye care for Allergan, discusses activity within the company. Dosanjh touches on recent acquisitions and the FDA approval of Vuity (pilocarpine HCl ophthalmic solution 1.25%).

Dec 3rd, 2021 - NEW ORLEANS — In this Healio Video Perspective from the AAO meeting, Philip Bloom, MD, discusses the role of endoscopic cyclophotocoagulation in the surgical management of glaucoma.

Dec 3rd, 2021 - NEW ORLEANS — In this Healio Video Perspective from the AAO meeting, Jay Stewart, MD, discusses his presentation on the Port Delivery System with ranibizumab, now called Susvimo (Genentech), including efficacy and safety study outcomes.

Dec 1st, 2021 - NEW ORLEANS — In this Healio Video Perspective from the AAO meeting, Raymond Douglas, MD, PhD, discusses results of a clinical trial examining adherence to teprotumumab and reasons for nonadherence in patients with thyroid eye disease.

Dec 1st, 2021 - NEW ORLEANS — In this Healio Video Perspective from the AAO meeting, Eric D. Donnenfeld, MD, discusses technologies available to automate astigmatism management, which can help overall patient outcomes.

Dec 1st, 2021 - To investigate how changing the injection duration at cardiac computed tomography angiography (CCTA) affects contrast enhancement in newborns and infants. Included were 142 newborns and infants with confirmed congenital heart disease who underwent CCTA between January 2015 and December 2018. In group 1 (n = 71 patients), the injection duration was 8 s; in group 2 (n = 71) it was 16 s. Our findi...

Nov 30th, 2021 - In this Healio Video Perspective, Cathleen McCabe, MD, discusses the phase 3 results of Vuity eye drops (pilocarpine HCl ophthalmic solution 1.25%, Allergan) for presbyopia.

Nov 29th, 2021 - NEW ORLEANS — Artificial intelligence may be used as a refractive surgery diagnostic tool, according to a speaker at Refractive Surgery Subspecialty Day at the American Academy of Ophthalmology meeting. “A robust [machine learning] process generally includes building new variables, which means feature engineering, choosing the most appropriate algorithm, optimizing its parameters, selecting the...

Nov 29th, 2021 - NEW ORLEANS — In this Healio Video Perspective from the AAO meeting, Brian Flowers, MD, discusses results of the Glaukos iStent infinite trial in patients with advanced glaucoma.

Nov 28th, 2021 - NEW ORLEANS — In this Healio Video Perspective from the AAO meeting, Robert Rothman, MD, co-founder and managing partner of InFocus Capital Partners, discusses Cellview Imaging’s ultra-high resolution, ultra-widefield fundus camera.

Nov 27th, 2021 - NEW ORLEANS — In this Healio Video Perspective from the Eyecelerator meeting, AnnMarie Hipsley, DPT, PhD, founder and CEO of Ace Vision Group, discusses the company’s product pipeline, including a product launch and clinical trial.

Nov 25th, 2021 - We explored lifetime comorbidities in clinical subsamples with a diagnosis of Psychosis (N = 143), bipolar (BD = 511), and unipolar disorders (UP = 861). We analyzed trajectories and patterns of comorbidities using novel metrics, namely bubble plots and density of antecedent events per year of illness exposure per individual. Age at onset (AAO) of most comorbidities was similar to epidemiologic...

Nov 24th, 2021 - NEW ORLEANS — In this Healio Video Perspective from the AAO meeting, David S. Boyer, MD, discusses 6-month results of the DAVIO trial, investigating EYP-1901 (EyePoint Pharmaceuticals) in patients with wet AMD.

Nov 23rd, 2021 - NEW ORLEANS — Patients with dry eye disease saw improvements in symptoms and signs after treatment with varenicline nasal spray, according to a study presented at the American Academy of Ophthalmology meeting. Marjan Farid, MD, said Tyrvaya (varenicline solution, Oyster Point Pharma), formerly known as OC-01, is a cholinergic agonist that leads to an increase in basal tear production with rapid...

Nov 23rd, 2021 - NEW ORLEANS — In this Healio Video Perspective from the AAO meeting, Yolande Barnard, vice president and general manager, U.S. Pharmaceuticals, Bausch + Lomb, discusses Xipere (triamcinolone acetonide injectable suspension). The therapy, from Bausch + Lomb and Clearside Biomedical, was recently approved as a suprachoroidal injection for the treatment of macular edema secondary to uveitis, Barna...

Nov 22nd, 2021 - NEW ORLEANS — When law enforcement uses rubber bullets — also called kinetic impact projectiles — during protests, there is a high risk for blindness and loss of the eye, according to a study. Nicole Koulisis, MD, said at the American Academy of Ophthalmology meeting that numerous reports emerged about blinding eye injuries among protesters due to kinetic impact projectiles (KIPs) used during d...

Nov 22nd, 2021 - NEW ORLEANS — Dan Z. Reinstein, MD, offered pearls for therapeutic custom ablation at Refractive Surgery Subspecialty Day at the American Academy of Ophthalmology meeting. “The key is that you need to have epithelial mapping, and it’s not just for therapeutic surgery,” Reinstein said. “You need it for keratoconus screening.” Reinstein described therapeutic refractive surgery as “trying to fix a...

Nov 22nd, 2021 - NEW ORLEANS — In this Healio Video Perspective from the Eyecelerator meeting, Greg Kunst, president and CEO of Aurion Biotech, discusses the potential of the company’s technology to work toward cures for corneal endothelial disease.

Nov 22nd, 2021 - This study sought to assess the predictive value of wall shear stress (WSS) for colocalized ascending aorta (AAo) growth rate (GR) in patients with bicuspid aortic valve (BAV). BAV is associated with AAo dilation, but there is limited knowledge about possible predictors of aortic dilation in BAV patients with BAV. An increased WSS has been related to aortic wall damage in patients with BAV, but...

Nov 21st, 2021 - NEW ORLEANS — In this Healio Video Perspective from the Eyecelerator meeting, Mohamed Abou Shousha, MD, discusses the launch and capabilities of new diagnostic technology platforms, including the Heru re:Vive.